Skip to Main Content

Working…

ClinicalTrials.gov Menu

Trial record 2 of 4 for: iBEAT

Previous Study | Return to List | Next Study

Prognostic Imaging Biomarkers for Diabetic Kidney Disease (iBEAt)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03716401

Recruitment Status : Recruiting

First Posted : October 23, 2018

Last Update Posted : January 11, 2021

See Contacts and Locations

Sponsor:

Collaborators:

University of Exeter

University Hospital of Bordeaux

University of Bari

University of Turku

Lund University

Swiss Institute of Bioinformatics

Information provided by (Responsible Party):

Steven Sourbron, University of Leeds

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Recruiting
Estimated Primary Completion Date :	September 1, 2022
Estimated Study Completion Date :	September 1, 2038

Publications:

Grenier N, Merville P, Combe C. Radiologic imaging of the renal parenchyma structure and function. Nat Rev Nephrol. 2016 Jun;12(6):348-59. doi: 10.1038/nrneph.2016.44. Epub 2016 Apr 12. Review.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Gooding KM, Lienczewski C, Papale M, Koivuviita N, Maziarz M, Dutius Andersson AM, Sharma K, Pontrelli P, Garcia Hernandez A, Bailey J, Tobin K, Saunavaara V, Zetterqvist A, Shelley D, Teh I, Ball C, Puppala S, Ibberson M, Karihaloo A, Metsärinne K, Banks RE, Gilmour PS, Mansfield M, Gilchrist M, de Zeeuw D, Heerspink HJL, Nuutila P, Kretzler M, Welberry Smith M, Gesualdo L, Andress D, Grenier N, Shore AC, Gomez MF, Sourbron S; BEAt-DKD consortium. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol. BMC Nephrol. 2020 Jun 29;21(1):242. doi: 10.1186/s12882-020-01901-x.